492 related articles for article (PubMed ID: 17055404)
1. The promise of South African biotech.
Akermann B; Kermani F
Drug Discov Today; 2006 Nov; 11(21-22):962-5. PubMed ID: 17055404
[No Abstract] [Full Text] [Related]
2. A new era of hope for the world's most neglected diseases.
The
PLoS Med; 2005 Sep; 2(9):e323. PubMed ID: 16138790
[TBL] [Abstract][Full Text] [Related]
3. The development of China's medical biotech industry needs to be driven by innovation.
Yu Z; Dai Y
Biotechnol J; 2006 Nov; 1(11):1253-7. PubMed ID: 17068752
[TBL] [Abstract][Full Text] [Related]
4. Public sector seeks to bridge 'valley of death'.
Moran N
Nat Biotechnol; 2007 Mar; 25(3):266. PubMed ID: 17344867
[No Abstract] [Full Text] [Related]
5. The interface between publicly funded and industry-funded research in pediatric psychopharmacology: opportunities for integration and collaboration.
Vitiello B; Heiligenstein JH; Riddle MA; Greenhill LL; Fegert JM
Biol Psychiatry; 2004 Jul; 56(1):3-9. PubMed ID: 15219466
[TBL] [Abstract][Full Text] [Related]
6. What's fueling the biotech engine?
Aggarwal S
Nat Biotechnol; 2007 Oct; 25(10):1097-104. PubMed ID: 17921989
[No Abstract] [Full Text] [Related]
7. Editorial: Biotech in the financial crisis.
Jungbauer A
Biotechnol J; 2009 Aug; 4(8):1095. PubMed ID: 19685457
[No Abstract] [Full Text] [Related]
8. Technology transfer: seeking a more efficient way.
Wilkinson JM
Med Device Technol; 2006; 17(9):36, 38-9. PubMed ID: 17240686
[TBL] [Abstract][Full Text] [Related]
9. Basic and applied research in India: present and future.
Ramasami T; Rao AV; Natesh S
Biotechnol J; 2009 Mar; 4(3):301-5. PubMed ID: 19296436
[No Abstract] [Full Text] [Related]
10. Biotech R&D still reeling.
Lawrence S
Nat Biotechnol; 2004 Sep; 22(9):1068. PubMed ID: 15340460
[No Abstract] [Full Text] [Related]
11. [Patent rights and the free research. The boundary between basic research and private sector is not longer razor-sharp].
Westerlund L
Lakartidningen; 2005 Sep 26-Oct 2; 102(39):2737. PubMed ID: 16245544
[No Abstract] [Full Text] [Related]
12. Research interactions between industry and academia: a corporate perspective.
Citron P
Physiologist; 1996 Jun; 39(3):81, 90-2. PubMed ID: 16764116
[No Abstract] [Full Text] [Related]
13. Gold in the ivory tower: equity rewards of outlicensing.
Edwards M; Murray F; Yu R
Nat Biotechnol; 2006 May; 24(5):509-15. PubMed ID: 16680129
[TBL] [Abstract][Full Text] [Related]
14. Europe caught in innovation quagmire.
Mitchell P
Nat Biotechnol; 2005 Sep; 23(9):1029. PubMed ID: 16151378
[No Abstract] [Full Text] [Related]
15. Innovation in biomedicine: can stem cell research lead the way to affordability?
Goozner M
PLoS Med; 2006 Feb; 3(5):e126. PubMed ID: 16492088
[TBL] [Abstract][Full Text] [Related]
16. Cultivating and investing in clinical research in China.
Zhang J; Huang H; Shen X
Lancet; 2015 Oct; 386(10002):1506-8. PubMed ID: 26466054
[No Abstract] [Full Text] [Related]
17. A breakthrough in R&D for neglected diseases: new ways to get the drugs we need.
Moran M
PLoS Med; 2005 Sep; 2(9):e302. PubMed ID: 16138789
[TBL] [Abstract][Full Text] [Related]
18. A status report on neuroscience research, without grade inflation.
Johnston SC; Hauser SL
Ann Neurol; 2006 Dec; 60(6):A9-11. PubMed ID: 17192939
[No Abstract] [Full Text] [Related]
19. The NIH, research institutions and industry: working together on a shared goal.
Omary MB
Gastroenterology; 2007 May; 132(5):1647-50. PubMed ID: 17484859
[No Abstract] [Full Text] [Related]
20. Biotechnology: delivering on the promise.
Greenwood JC
Sci Transl Med; 2010 Jan; 2(13):13cm1. PubMed ID: 20371460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
